Position in NVO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$328,053
+$25,270 QoQ
Shares Held
6,843
-16.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#857
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAUREL OAK WEALTH MANAGEMENT, LLC holds $15,316,010 across 11 Drug Manufacturers - General names. NVO ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,043 | $4,849,295 | |
| 2 | JNJ |
Johnson & Johnson
|
18,396 | $4,672,032 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,626 | $1,493,941 | |
| 4 | ABBV |
AbbVie Inc.
|
3,889 | $978,627 | |
| 5 | AMGN |
Amgen Inc
|
2,554 | $924,854 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
11,961 | $689,192 | |
| 7 | PFE |
Pfizer Inc
|
22,641 | $545,195 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
6,843 | $328,053 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,053 | 6,843 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $302,783 | 8,239 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $562,631 | 11,058 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||